Company Active LTD

Company profile

Open Medical Ltd

Open Medical | Pathpoint Clinical Workflows | United Kingdom

From the creators of eTrauma and eDerma - Open Medical brings Pathpoint as a new clinical workflow management systems that allows clinicians to digitise their care pathways to triage, track and review patients.

CRN
08620208
Founded
2013
Age
12

Overview

Legal name
OPEN MEDICAL LTD
Region
Unknown
Registered address
C P HOUSE 97 -107 UXBRIDGE ROAD
EALING
LONDON
UNITED KINGDOM
W5 5TL
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller
1
Company Active LTD
Open Medical Ltd
CRN 08620208
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

9 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

18 Jun
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

07 Jun
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUyNTU4MDIzOWFkaXF6a2N4

Published 07 Jun 2026 07:31

07 Jun
2026

Change Person Director Company With Change Date

Officers

CH01 | Transaction MzUyNTU4MDM4NmFkaXF6a2N4

Published 07 Jun 2026 07:27

04 Jun
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

30 Sep
2024

Appoint Person Secretary Company With Name Date

Officers

AP03 | Transaction MzQzNzc2NjU1MGFkaXF6a2N4

Published 30 Sep 2024 02:46

30 Sep
2024

Termination Secretary Company With Name Termination Date

Officers

TM02 | Transaction MzQzNzc2NjIwOGFkaXF6a2N4

Published 30 Sep 2024 02:45

23 Jul
2013

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2020
Funded years
2020, 2026
Age at first award
6 years

Projects

2026 Collaborative R&D Lead participant

Pathpoint FLS: An AI-Enabled Platform for Closing the Osteoporosis Treatment Gap in Europe

1 May 2026 to 30 Apr 2028

Awarded
£186,207
Total cost £310,345

Fragility fractures caused by osteoporosis are a major and growing health challenge across the UK and Europe. After an initial fracture, patients are at very high risk of suffering further, often more serious fractures, yet the majority are never assessed or treated to reduce this risk. This gap exists not because of a lack of clinical guidance, but becau...

2020 Collaborative R&D Lead participant

Pathpoint SurgiCare - Delivering Safe Surgical Care

1 Nov 2020 to 30 Apr 2021

Awarded
£99,585
Total cost £99,585

Pathpoint SurgiCare is a digital solution to tackle the surgery waiting list backlog resulting from the drastic service interruption brought about by COVID-19\. The software captures and communicates all the relevant information required to prioritise patients for surgery; from pre-admission tests to post-discharge review and rehabilitation. Using cloud t...

2020 Collaborative R&D Lead participant

Pathpoint Restore: Joining Up Critical Illness Recovery

1 Oct 2020 to 30 Sep 2021

Awarded
£174,858
Total cost £220,224

The volume and dependency of critical care survivors now highlights the lack of a comprehensive and integrated national care pathway for patients and their carers. Pathpoint Restore fulfils the urgent need for a joined-up pan-regional platform to digitally coordinate the full critical care patient journey; from acute trust care to home-based rehabilitatio...

2020 Feasibility Studies Lead participant

Pathpoint ITU- 'cloud' solution to triage, track and review intensive care patients

1 May 2020 to 31 Mar 2021

Awarded
£75,463
Total cost £75,463

Intensive Treatment Unit (ITU) is the highest level of treatment for the most sick patients in society. Covid-19 is a novel infection with no known cure currently, leading to severe organ failure in the worst affected patients. Currently intensive care doctors are managing their highest number of patients in the history of the NHS. With high numbers of pa...

Product types

Collaborative R&D Feasibility Studies